Treatment (4 h) of jejunal crypts from TAS2R43+ patients with obesity with the TAS2R43 agonist aloin (30 M, n = 6) versus vehicle (n = 8) resulted in the identification of 10 DEGs (Figure 7, E and F). This evidence concerns the gene TAS2R43 and obesity disorder.